Skip to main content
NCBI home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1993 Jul;53(1):96–104.

Molecular definition of a chromosome 9p21 germ-line deletion in a woman with multiple melanomas and a plexiform neurofibroma: implications for 9p tumor-suppressor gene(s).

E M Petty 1, L H Gibson 1, J W Fountain 1, J L Bolognia 1, T L Yang-Feng 1, D E Housman 1, A E Bale 1
PMCID: PMC1682234  PMID: 8317504

Abstract

Cutaneous malignant melanoma (CMM) is often familial, but the mode of inheritance and the chromosomal location of melanoma susceptibility locus are controversial. Identification of a 34-year-old woman with eight primary malignant melanomas, multiple atypical moles, and a de novo constitutional cytogenetic rearrangement involving chromosomes 5p and 9p suggested the presence of a melanoma predisposition gene at one of these locations. A high-resolution karyotype showed a partial deletion of a dark-staining Giemsa band, either 5p14 or 9p21. The patient was heterozygous for five 5p14 RFLPs. In situ hybridization with D9S3 indicated that this 9p21 marker was deleted. Gene dosage studies demonstrated the deletion of two more distal 9p21 markers, D9S126 and IFNA. In addition, she was hemizygous for the more proximal 9p21 short tandem-repeat polymorphism at D9S104. D9S18, D9S19, and D9S33 were retained, localizing the deletion to 9p21 between D9S19 on the proximal side and D9S33 on the distal side. Pulsed-field gel electrophoresis with D9S19 and D9S33 did not reveal any junction fragments in the patient's DNA. This germ-line deletion suggests that mutations in a 9p21 gene may initiate melanoma tumorigenesis.

Full text

PDF
96

Images in this article

100Figure 1
on p.100
101Figure 2
on p.101
101Figure 3
on p.101

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Balaban G. B., Herlyn M., Clark W. H., Jr, Nowell P. C. Karyotypic evolution in human malignant melanoma. Cancer Genet Cytogenet. 1986 Jan 1;19(1-2):113–122. doi: 10.1016/0165-4608(86)90378-x. [DOI] [PubMed] [Google Scholar]
  2. Bale S. J., Dracopoli N. C., Tucker M. A., Clark W. H., Jr, Fraser M. C., Stanger B. Z., Green P., Donis-Keller H., Housman D. E., Greene M. H. Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p. N Engl J Med. 1989 May 25;320(21):1367–1372. doi: 10.1056/NEJM198905253202102. [DOI] [PubMed] [Google Scholar]
  3. Cannon-Albright L. A., Goldgar D. E., Meyer L. J., Lewis C. M., Anderson D. E., Fountain J. W., Hegi M. E., Wiseman R. W., Petty E. M., Bale A. E. Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22. Science. 1992 Nov 13;258(5085):1148–1152. doi: 10.1126/science.1439824. [DOI] [PubMed] [Google Scholar]
  4. Cannon-Albright L. A., Goldgar D. E., Wright E. C., Turco A., Jost M., Meyer L. J., Piepkorn M., Zone J. J., Skolnick M. H. Evidence against the reported linkage of the cutaneous melanoma-dysplastic nevus syndrome locus to chromosome Ip36. Am J Hum Genet. 1990 May;46(5):912–918. [PMC free article] [PubMed] [Google Scholar]
  5. Clark W. H., Jr, Reimer R. R., Greene M., Ainsworth A. M., Mastrangelo M. J. Origin of familial malignant melanomas from heritable melanocytic lesions. 'The B-K mole syndrome'. Arch Dermatol. 1978 May;114(5):732–738. [PubMed] [Google Scholar]
  6. Cowan J. M., Halaban R., Francke U. Cytogenetic analysis of melanocytes from premalignant nevi and melanomas. J Natl Cancer Inst. 1988 Sep 21;80(14):1159–1164. doi: 10.1093/jnci/80.14.1159. [DOI] [PubMed] [Google Scholar]
  7. Diaz M. O., Ziemin S., Le Beau M. M., Pitha P., Smith S. D., Chilcote R. R., Rowley J. D. Homozygous deletion of the alpha- and beta 1-interferon genes in human leukemia and derived cell lines. Proc Natl Acad Sci U S A. 1988 Jul;85(14):5259–5263. doi: 10.1073/pnas.85.14.5259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dracopoli N. C., Alhadeff B., Houghton A. N., Old L. J. Loss of heterozygosity at autosomal and X-linked loci during tumor progression in a patient with melanoma. Cancer Res. 1987 Aug 1;47(15):3995–4000. [PubMed] [Google Scholar]
  9. Dracopoli N. C., Bale S. J. Genetic aspects of cutaneous malignant melanoma. Semin Oncol. 1988 Dec;15(6):541–548. [PubMed] [Google Scholar]
  10. Fearon E. R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990 Jun 1;61(5):759–767. doi: 10.1016/0092-8674(90)90186-i. [DOI] [PubMed] [Google Scholar]
  11. Fountain J. W., Karayiorgou M., Ernstoff M. S., Kirkwood J. M., Vlock D. R., Titus-Ernstoff L., Bouchard B., Vijayasaradhi S., Houghton A. N., Lahti J. Homozygous deletions within human chromosome band 9p21 in melanoma. Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10557–10561. doi: 10.1073/pnas.89.21.10557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Fountain J. W., Karayiorgou M., Taruscio D., Graw S. L., Buckler A. J., Ward D. C., Dracopoli N. C., Housman D. E. Genetic and physical map of the interferon region on chromosome 9p. Genomics. 1992 Sep;14(1):105–112. doi: 10.1016/s0888-7543(05)80290-3. [DOI] [PubMed] [Google Scholar]
  13. Frichot B. C., 3rd, Lynch H. T., Guirgis H. A., Harris R. E., Lynch J. F. New cutaneous phenotype in familial malignant melanoma. Lancet. 1977 Apr 16;1(8016):864–865. doi: 10.1016/s0140-6736(77)92822-7. [DOI] [PubMed] [Google Scholar]
  14. Friedman R. J., Rigel D. S., Silverman M. K., Kopf A. W., Vossaert K. A. Malignant melanoma in the 1990s: the continued importance of early detection and the role of physician examination and self-examination of the skin. CA Cancer J Clin. 1991 Jul-Aug;41(4):201–226. doi: 10.3322/canjclin.41.4.201. [DOI] [PubMed] [Google Scholar]
  15. Fällström S. P., Wahlström J. A pericentric inversion of chromosome 9 and a rearrangement involving chromosomes 9 and 10, observed in two generations. Clinical description of chromosome 9 (p12-p21) deletion syndrome. Clin Genet. 1979 Jun;15(6):480–486. doi: 10.1111/j.1399-0004.1979.tb00829.x. [DOI] [PubMed] [Google Scholar]
  16. Grammatico P., Lo Re M. L., Scarpa S., Modesti A., Del Porto G. Human malignant melanoma. Significance of chromosomal abnormalities. Cancer Genet Cytogenet. 1990 Sep;48(2):237–242. doi: 10.1016/0165-4608(90)90126-u. [DOI] [PubMed] [Google Scholar]
  17. Greene M. H., Clark W. H., Jr, Tucker M. A., Kraemer K. H., Elder D. E., Fraser M. C. High risk of malignant melanoma in melanoma-prone families with dysplastic nevi. Ann Intern Med. 1985 Apr;102(4):458–465. doi: 10.7326/0003-4819-102-4-458. [DOI] [PubMed] [Google Scholar]
  18. James C. D., He J., Carlbom E., Nordenskjold M., Cavenee W. K., Collins V. P. Chromosome 9 deletion mapping reveals interferon alpha and interferon beta-1 gene deletions in human glial tumors. Cancer Res. 1991 Mar 15;51(6):1684–1688. [PubMed] [Google Scholar]
  19. Jeanpierre M. A rapid method for the purification of DNA from blood. Nucleic Acids Res. 1987 Nov 25;15(22):9611–9611. doi: 10.1093/nar/15.22.9611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Kefford R. F., Salmon J., Shaw H. M., Donald J. A., McCarthy W. H. Hereditary melanoma in Australia. Variable association with dysplastic nevi and absence of genetic linkage to chromosome 1p. Cancer Genet Cytogenet. 1991 Jan;51(1):45–55. doi: 10.1016/0165-4608(91)90007-h. [DOI] [PubMed] [Google Scholar]
  21. Knudson A. G., Jr Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A. 1971 Apr;68(4):820–823. doi: 10.1073/pnas.68.4.820. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Lichter P., Tang C. J., Call K., Hermanson G., Evans G. A., Housman D., Ward D. C. High-resolution mapping of human chromosome 11 by in situ hybridization with cosmid clones. Science. 1990 Jan 5;247(4938):64–69. doi: 10.1126/science.2294592. [DOI] [PubMed] [Google Scholar]
  23. Lukeis R., Irving L., Garson M., Hasthorpe S. Cytogenetics of non-small cell lung cancer: analysis of consistent non-random abnormalities. Genes Chromosomes Cancer. 1990 Jul;2(2):116–124. doi: 10.1002/gcc.2870020207. [DOI] [PubMed] [Google Scholar]
  24. Lynch H. T., Frichot B. C., 3rd, Lynch J. F. Familial atypical multiple mole-melanoma syndrome. J Med Genet. 1978 Oct;15(5):352–356. doi: 10.1136/jmg.15.5.352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Miyakoshi J., Dobler K. D., Allalunis-Turner J., McKean J. D., Petruk K., Allen P. B., Aronyk K. N., Weir B., Huyser-Wierenga D., Fulton D. Absence of IFNA and IFNB genes from human malignant glioma cell lines and lack of correlation with cellular sensitivity to interferons. Cancer Res. 1990 Jan 15;50(2):278–283. [PubMed] [Google Scholar]
  26. Nancarrow D. J., Palmer J. M., Walters M. K., Kerr B. M., Hafner G. J., Garske L., McLeod G. R., Hayward N. K. Exclusion of the familial melanoma locus (MLM) from the PND/D1S47 and MYCL1 regions of chromosome arm 1p in 7 Australian pedigrees. Genomics. 1992 Jan;12(1):18–25. doi: 10.1016/0888-7543(92)90401-d. [DOI] [PubMed] [Google Scholar]
  27. Olopade O. I., Bohlander S. K., Pomykala H., Maltepe E., Van Melle E., Le Beau M. M., Diaz M. O. Mapping of the shortest region of overlap of deletions of the short arm of chromosome 9 associated with human neoplasia. Genomics. 1992 Oct;14(2):437–443. doi: 10.1016/s0888-7543(05)80238-1. [DOI] [PubMed] [Google Scholar]
  28. Pedersen M. I., Wang N. Chromosomal evolution in the progression and metastasis of human malignant melanoma. A multiple lesion study. Cancer Genet Cytogenet. 1989 Sep;41(2):185–201. doi: 10.1016/0165-4608(89)90245-8. [DOI] [PubMed] [Google Scholar]
  29. Petty E. M., Bolognia J. L., Bale A. E., Yang-Feng T. Cutaneous malignant melanoma and atypical moles associated with a constitutional rearrangement of chromosomes 5 and 9. Am J Med Genet. 1993 Jan 1;45(1):77–80. doi: 10.1002/ajmg.1320450119. [DOI] [PubMed] [Google Scholar]
  30. Rigel D. S., Kopf A. W., Friedman R. J. The rate of malignant melanoma in the United States: are we making an impact? J Am Acad Dermatol. 1987 Dec;17(6):1050–1053. doi: 10.1016/s0190-9622(87)80487-5. [DOI] [PubMed] [Google Scholar]
  31. Risch N., Sherman S. Genetic Analysis Workshop 7: summary of the melanoma workshop. Cytogenet Cell Genet. 1992;59(2-3):148–158. doi: 10.1159/000133230. [DOI] [PubMed] [Google Scholar]
  32. Silverberg E., Boring C. C., Squires T. S. Cancer statistics, 1990. CA Cancer J Clin. 1990 Jan-Feb;40(1):9–26. [PubMed] [Google Scholar]
  33. Smoller B. R., McNutt N. S., Hsu A. HMB-45 staining of dysplastic nevi. Support for a spectrum of progression toward melanoma. Am J Surg Pathol. 1989 Aug;13(8):680–684. doi: 10.1097/00000478-198908000-00006. [DOI] [PubMed] [Google Scholar]
  34. Tayel S. M., Kurczynski T. W., Casperson S., McCorquodale M. M. Deletion 9p, duplication 18q in two sisters resulting from a maternal (9;18) (p22;q21.3) translocation. Am J Med Genet. 1988 Dec;31(4):853–861. doi: 10.1002/ajmg.1320310419. [DOI] [PubMed] [Google Scholar]
  35. Wilkie P. J., Krizman D. B., Weber J. L. Linkage map of human chromosome 9 microsatellite polymorphisms. Genomics. 1992 Mar;12(3):607–609. doi: 10.1016/0888-7543(92)90456-3. [DOI] [PubMed] [Google Scholar]
  36. van Haeringen A., Bergman W., Nelen M. R., van der Kooij-Meijs E., Hendrikse I., Wijnen J. T., Khan P. M., Klasen E. C., Frants R. R. Exclusion of the dysplastic nevus syndrome (DNS) locus from the short arm of chromosome 1 by linkage studies in Dutch families. Genomics. 1989 Jul;5(1):61–64. doi: 10.1016/0888-7543(89)90086-4. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES